EPO Enlarged Board of Appeal rules intervener cannot inherit appellant status

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

EPO Enlarged Board of Appeal rules intervener cannot inherit appellant status

Sponsored by

inspicos-400px recrop.jpg
EPO sign.jpg

Edward J Farrington of Inspicos explains how G 2/24 confirms that a third-party intervener does not acquire appellant status once all original appeals are withdrawn

Article 105 of the European Patent Convention (EPC) allows a third party who is defending themselves in infringement proceedings before national European courts, or who has started non-infringement proceedings, to intervene in pending opposition proceedings, even if the deadline for filing an opposition has expired.

The so-called intervention gives a defendant an opportunity to challenge a European patent at the EPO, without having to rely on existing opposition proceedings.

The Enlarged Board of Appeal at the EPO has recently ruled in decision G 2/24 on a particular aspect of the intervention process.

In the referring case (T 1286/23), opposition proceedings were concluded with the issuance of a written decision. A notice of appeal was duly filed by the opponent. Shortly thereafter, a third party filed an intervention under Article 105 of the EPC, paid the opposition and appeal fees, and filed their arguments against the patent.

A few months later, the sole opponent withdrew their appeal. According to established case law of the EPO, withdrawal of the sole appeal should terminate appeal proceedings immediately. The questions posed by the referring case were:

  • Whether the appeal proceedings could be continued with a third party who intervened during appeal proceedings; and

  • If so, what status does this party acquire?

The answer provided by the Enlarged Board of Appeal on September 25 2025 is to-the-point. Decision G 2/24 found that – after withdrawal of all appeals – appeal proceedings may not be continued with a third party who intervened during the appeal proceedings. Also, G 2/24 found that the intervening third party does not acquire appellant status.

It seems that the status of intervening third parties is therefore somewhat unsafe, if they only intervened in appeal proceedings, as it depends on the actions of the ‘true’ appellants. To avoid this uncertainty, it is important that – wherever possible – interventions are filed during opposition proceedings, and not solely during appeal proceedings.

more from across site and SHARED ros bottom lb

More from across our site

Inès Garlantezec, who became principal of the firm’s Luxembourg office earlier this year, discusses what's been keeping her busy, including settling a long-running case
In the sixth episode of a podcast series celebrating the tenth anniversary of IP Inclusive, we discuss IP Futures, a network for early-career stage IP professionals
Rachel Cohen has reunited with her former colleagues to strengthen Weil’s IP litigation and strategy work
McKool Smith’s Jennifer Truelove explains how a joint effort between her firm and Irell & Manella secured a win for their client against Samsung
Tilleke & Gibbins topped the leaderboard with four awards across the region, while Anand & Anand and Kim & Chang emerged as outstanding domestic firms
News of a new addition to Via LA’s Qi wireless charging patent pool, and potential fee increases at the UKIPO were also among the top talking points
The keenly awaited ruling should act as a ‘call to arms’ for a much-needed evolution of UK copyright law, says Rebecca Newman at Addleshaw Goddard
Lawyers at Lavoix provide an overview of the UPC’s approach to inventive step and whether the forum is promoting its own approach rather than following the EPO
Andrew Blattman, who helped IPH gain significant ground in Asia and Canada, will leave in the second half of 2026
The court ordering a complainant to rank its arguments in order of potential success and a win for Edwards Lifesciences were among the top developments in recent weeks
Gift this article